The BDO Transaction Services team acted as Reporting Accountant on the recent AIM IPO of Midatech Pharma plc (‘Midatech’). Based in Oxford, Midatech is a nano-medicine company developing and commercialising multiple therapeutic products to enhance the delivery of medicines in major diseases with high unmet medical needs. The group's two platform technologies are designed to enable targeted delivery ('right place') and sustained release ('right time') of existing therapeutic drugs.
Upon admission, Midatech also completed its acquisition of Q Chip Limited and its subsidiaries, a sustained release specialist company based in Wales that has developed complementary technology and products.
“The support provided by BDO during the IPO of Midatech Pharma PLC was invaluable. They were utterly professional throughout but quickly became part of the Midatech Pharma team and worked tirelessly to ensure milestones were met and the overall timetable was achieved. Where possible, BDO staff took the initiative and they were always looking for ways to solve problems as they arose that didn’t require extra work for Midatech Pharma staff.”
Nick Robbins-Cherry, Finance Director